Is Stroke a Neurodegenerative Condition? A Critical Review of Secondary Neurodegeneration and Amyloid-beta Accumulation after Stroke

Stroke-induced secondary neurodegeneration (SND) refers to the progressive and inexorable loss of tissues at sites connected to area damaged by the initial infarction. SND has been consistently observed to occur in humans and rodents after stroke. Intriguingly, stroke-induced SND shares a number of...

Full description

Bibliographic Details
Main Authors: Lin Kooi Ong, Frederick Rohan Walker, Michael Nilsson
Format: Article
Language:English
Published: American Institute of Mathematical Sciences 2017-01-01
Series:AIMS Medical Science
Subjects:
Online Access:http://www.aimspress.com/medicalScience/article/1201/fulltext.html
id doaj-e0ff35ea115745d9bf8ea9973ef8505a
record_format Article
spelling doaj-e0ff35ea115745d9bf8ea9973ef8505a2020-11-25T01:02:50ZengAmerican Institute of Mathematical SciencesAIMS Medical Science2375-15762017-01-014111610.3934/medsci.2017.1.1medsci-04-00001Is Stroke a Neurodegenerative Condition? A Critical Review of Secondary Neurodegeneration and Amyloid-beta Accumulation after StrokeLin Kooi OngFrederick Rohan WalkerMichael NilssonStroke-induced secondary neurodegeneration (SND) refers to the progressive and inexorable loss of tissues at sites connected to area damaged by the initial infarction. SND has been consistently observed to occur in humans and rodents after stroke. Intriguingly, stroke-induced SND shares a number of striking similarities to other neurodegenerative diseases such as Alzheimer’s disease, most notably with respect to the significant accumulation of the neurotoxic protein amyloid-β. Together, this observation and others (progressive neuronal loss and neuroinflammation) suggest the possibility that <em>stroke may induce a neurodegenerative condition</em>. Certainly, this is supported to some degree by the relatively high incidence of dementia after stroke. We begin this review by addressing the available research on human and rodent SND pathology after stroke. We next consider amyloid-β in the context of SND. We discuss what amyloid-β is, how is it made, and introduce some caveats on how amyloid-β measurements should be interpreted. In summary, we conclude that there is now robust pre-clinical evidence demonstrating the presence of amyloid disturbances at sites of SND after stroke. We find, however, that the human literature on the topic is more limited and further work is warranted. While the understanding of amyloid disturbances remains inconclusive in human studies, stroke clearly lead to the development of a neurodegenerative-like condition at the sites of SND, with prominent features such as death of neurons and gliosis.http://www.aimspress.com/medicalScience/article/1201/fulltext.htmlAmyloid-betaaggregationsecondary neurodegenerationstrokethalamusPittsburgh compound B
collection DOAJ
language English
format Article
sources DOAJ
author Lin Kooi Ong
Frederick Rohan Walker
Michael Nilsson
spellingShingle Lin Kooi Ong
Frederick Rohan Walker
Michael Nilsson
Is Stroke a Neurodegenerative Condition? A Critical Review of Secondary Neurodegeneration and Amyloid-beta Accumulation after Stroke
AIMS Medical Science
Amyloid-beta
aggregation
secondary neurodegeneration
stroke
thalamus
Pittsburgh compound B
author_facet Lin Kooi Ong
Frederick Rohan Walker
Michael Nilsson
author_sort Lin Kooi Ong
title Is Stroke a Neurodegenerative Condition? A Critical Review of Secondary Neurodegeneration and Amyloid-beta Accumulation after Stroke
title_short Is Stroke a Neurodegenerative Condition? A Critical Review of Secondary Neurodegeneration and Amyloid-beta Accumulation after Stroke
title_full Is Stroke a Neurodegenerative Condition? A Critical Review of Secondary Neurodegeneration and Amyloid-beta Accumulation after Stroke
title_fullStr Is Stroke a Neurodegenerative Condition? A Critical Review of Secondary Neurodegeneration and Amyloid-beta Accumulation after Stroke
title_full_unstemmed Is Stroke a Neurodegenerative Condition? A Critical Review of Secondary Neurodegeneration and Amyloid-beta Accumulation after Stroke
title_sort is stroke a neurodegenerative condition? a critical review of secondary neurodegeneration and amyloid-beta accumulation after stroke
publisher American Institute of Mathematical Sciences
series AIMS Medical Science
issn 2375-1576
publishDate 2017-01-01
description Stroke-induced secondary neurodegeneration (SND) refers to the progressive and inexorable loss of tissues at sites connected to area damaged by the initial infarction. SND has been consistently observed to occur in humans and rodents after stroke. Intriguingly, stroke-induced SND shares a number of striking similarities to other neurodegenerative diseases such as Alzheimer’s disease, most notably with respect to the significant accumulation of the neurotoxic protein amyloid-β. Together, this observation and others (progressive neuronal loss and neuroinflammation) suggest the possibility that <em>stroke may induce a neurodegenerative condition</em>. Certainly, this is supported to some degree by the relatively high incidence of dementia after stroke. We begin this review by addressing the available research on human and rodent SND pathology after stroke. We next consider amyloid-β in the context of SND. We discuss what amyloid-β is, how is it made, and introduce some caveats on how amyloid-β measurements should be interpreted. In summary, we conclude that there is now robust pre-clinical evidence demonstrating the presence of amyloid disturbances at sites of SND after stroke. We find, however, that the human literature on the topic is more limited and further work is warranted. While the understanding of amyloid disturbances remains inconclusive in human studies, stroke clearly lead to the development of a neurodegenerative-like condition at the sites of SND, with prominent features such as death of neurons and gliosis.
topic Amyloid-beta
aggregation
secondary neurodegeneration
stroke
thalamus
Pittsburgh compound B
url http://www.aimspress.com/medicalScience/article/1201/fulltext.html
work_keys_str_mv AT linkooiong isstrokeaneurodegenerativeconditionacriticalreviewofsecondaryneurodegenerationandamyloidbetaaccumulationafterstroke
AT frederickrohanwalker isstrokeaneurodegenerativeconditionacriticalreviewofsecondaryneurodegenerationandamyloidbetaaccumulationafterstroke
AT michaelnilsson isstrokeaneurodegenerativeconditionacriticalreviewofsecondaryneurodegenerationandamyloidbetaaccumulationafterstroke
_version_ 1725203403169071104